Welcome to HelixTalk -- a podcast presented by the Rosalind Franklin University College of Pharmacy

This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.

How Do I Listen?

Find us in iTunes under the name HelixTalk Add us to your mobile app via our RSS feed Listen to any past episode in your browser (below)
iTunes link to HelixTalk RSS feed for HelixTalk

Contact Us

Would you like to recommend content for a new podcast episode or provide your own commentary about a previous episode?  We love feedback from our listeners!  To contact us, please email Sean Kane (sean.kane@rosalindfranklin.edu).

HelixTalk Episodes

Episode 12 - Osteoporosis Guidelines and Two Newer Agents

September 9, 2014

In this episode, we review the National Osteoporosis Foundation's osteoporosis guidelines with a particular focus on two newer agents, denosumab (Prolia) and teriparatide (Forteo).


Episode 11 - Bordetella pertussis

August 26, 2014

In this episode, we discuss Bordetella pertussis (whooping cough) with Dr. Michael Fennewald.


Episode 10 - Pet Peeves

August 12, 2014

In this episode, we discuss our clinical "pet peeves" covering allergy histories, creatinine clearance, surrogate endpoints, "me too" enantiomer drugs, and dose-dependent pharmacology of psychiatric medications.


Episode 9 - Combining ACE-I, ARB, and DRIs

July 29, 2014

In this episode, we discuss the pharmacology of the renin-angiotensin-aldosterone system and review the evidence for combining ACE-Is, ARBs, and/or DRIs.


Episode 8 - HCAP, HAP, and VAP

July 15, 2014

In this episode, we discuss the 2005 ATS/IDSA Healthcare-Associated, Hospital-Acquired, and Ventilator-Associated Pneumonia Guidelines (HCAP, HAP, VAP).


Episode 7 - Community-Acquired Pneumonia Guidelines

July 1, 2014

In this episode, we discuss the 2007 ATS/IDSA Community-Acquired Pneumonia (CAP) guidelines.


Episode 6 - Updates to GOLD Guidelines and COPD

June 17, 2014

In this episode, we discuss updates to the GOLD guidelines for COPD and review the newer agents for COPD including roflumilast (Daliresp), indacaterol (Arcapta Neohaler), aclidinium (Tudorza Pressair), umeclidinium/vilanterol (Anoro Ellipta), and fluticasone/vilanterol (Breo Ellipta).


Episode 5 - Smoking Cessation

June 3, 2014

In this episode, we discuss smoking cessation, including nicotine replacement therapy, bupropion (Zyban), and varenicline (Chantix).


Episode 4 - P2Y12 Inhibitors, DAPT, and TOAT

May 20, 2014

In this episode, we discuss the P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) and the role of dual antiplatelet therapy (DAPT) and triple oral antithrombotic therapy (TOAT).


Episode 3 - Novel Oral Anticoagulants (NOACs)

May 6, 2014

In this episode, we discuss the new drug class of Novel Oral Anticoagulants (NOACs), which include dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis).


Episode 2 - Antihypertension Guidelines (JNC 8 and more)

April 22, 2014

In this episode, we discuss the new JNC 8 guidelines and how these guidelines differ from other hypertension guidelines released in 2013-2014.


Episode 1 - 2013 ACC/AHA Lipid Guidelines

April 8, 2014

In this episode, we discuss the new, rebranded podcast (HelixTalk) and review the new ACC/AHA 2013 lipid guidelines.


Past Episodes - Top 200 Drugs Podcast (pre-HelixTalk)

Women’s Health – Spring 2013, Week 10

April 25, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss women’s health: conjugated estrogens, ethinyl estradiol, norethindrone, norgestrel, etonogestrel, medroxyprogesterone, raloxifene, tamoxifen, miconazole, Midol, phenazopyridine.


GI Medications – Spring 2013, Week 9

April 17, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss GI medications: methotrexate, allopurinol, mesalamine, esomeprazole, pantoprazole, rabeprazole, sucralfate, dicyclomine, simethicone, pyrantel, and lactase enzyme.


Antiemetics, Antitussives, Antihistamines – Spring 2013, Week 8

April 9, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antiemetics, antitussives, and antihistamines: hydroxyzine, meclizine, metoclopramide, prochlorperazine, ondansetron, chlorpheniramine/hydrocodone, promethazine/codeine, desloratadine, dimehydrinate, benzoyl peroxide, and salicylic acid.


Men’s Health – Spring 2013, Week 7

April 3, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss men’s health: terazosin, doxazosin, tamsulosin, finasteride, sildenafil, vardenafil, tadalafil, oxybutynin, tolterodine, minoxidil, and nonoxynol-9.


Muscle Relaxants, Stimulants, Anticonvulsants – Spring 2013, Week 5

March 20, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss muscle relaxants, stimulants, and anticonvulsants: baclofen, carisoprodol, metaxalone, cyclobenzaprine, methylphenidate, Adderall, lisdexamfetamine, phenytoin, divalproex, DEET, tolnaftate, and eucerin.


Antidepressants, Antipsychotics – Spring 2013, Week 4

March 14, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antidepressants and antipsychotics: bupropion, venlafaxine, aripiprazole, quetiapine, risperidone, olanzapine, carbidopa/levodopa, pramoxine, Neosporin, and povidone/iodine.


Antidepressants – Spring 2013, Week 3

March 5, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antidepressants: citalopram, escitalopram, sertraline, fluoxetine, paroxetine, duloxetine, amitriptyline, trazodone, fexofenadine, oxymetazoline, and pheniramine.


Sleep Agents, Neuropathic Pain – Spring 2013, Week 2

February 26, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss sleep agents and neuropathic pain: alprazolam, clonazepam, diazepam, lorazepam, zolpidem, zaleplon, gabapentin, pregabalin, and lidocaine.


Osteoporosis – Winter 2012, Week 11

January 31, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss agents for osteoporosis: calcitonin, alendronate, risedronate, ibandronate, potassium chloride, and calcium citrate.


COPD, Asthma – Winter 2012, Week 10

January 26, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss agents for COPD and asthma: albuterol, levalbuterol, ipratropium, tiotropium, albuterol/ipratropium, fluticasone, mometasone, fluticasone/salmeterol, and formoterol/budesonide.


Opioid Analgesics – Winter 2012, Week 9

January 16, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss opioid analgesics: morphine sulfate, codeine/APAP, oxycodone, oxycodone/APAP, hydrocodone/APAP, hydrocodone/ibuprofen, fentanyl, and bisacodyl.


Pain Relievers – Winter 2012, Week 8

January 14, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss pain relievers: meloxicam, celecobix, ketorolac, tramadol, tramadol/APAP, capsaicin, and methyl salicylate.


Antifungals, Antivirals – Winter 2012, Week 7

January 14, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antifungals and antivirals: fluconazole, itraconazole, ketoconazole, oseltamivir, acyclovir, valacyclovir, docosanol, terbinafine, and clotrimazole or miconazole.


Antibiotics – Winter 2012, Week 6 

January 14, 2013

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antibiotics: metronidazole, clindamycin, doxycycline, nitrofurantoin, sulfamethoxazole/trimethoprim, mupirocin, zinc oxide, and polyethylene glycol 400.

Life in Discovery
College of Pharmacy Home
Philanthropic Opportunities
Employment Opportunities
3333 Green Bay Road, North Chicago, Il 60064-3095 • 847-578-3000